Mechanisms of statin-induced new-onset diabetes

Area of Science:

• Biochemistry
• Endocrinology
• Pharmacology

Background:

• Statins are primary treatments for cardiovascular disease due to their lipid-lowering effects.
• Emerging research indicates a potential link between statin use and an increased risk of new-onset diabetes (NOD).

Purpose of the Study:

• To review and discuss the proposed molecular and pathophysiological mechanisms underlying statin-induced new-onset diabetes.
• To highlight the clinical relevance of understanding these mechanisms for future therapeutic strategies.

Main Methods:

• Literature review and synthesis of existing evidence on statin-induced diabetes.
• Discussion of proposed mechanisms involving pancreatic beta cells, adipocytes, and genetic/epigenetic factors.

Main Results:

• Statin-induced NOD may involve alterations in beta-cell function, including insulin secretion and signaling pathways.
• Mechanisms outside the beta cell include effects on adipocytes and modulation of adipokines like leptin and adiponectin.
• Genetic and epigenetic factors, such as microRNA alterations, are also implicated.

Conclusions:

• Understanding the mechanisms of statin-induced NOD is crucial for clinical practice.
• This knowledge may lead to the development of preventative strategies or novel statin generations with reduced diabetic side effects.